-
Mashup Score: 6
Join us for a collaborative webinar hosted by IDSA and ESCMID to explore critical updates on the Marburg Virus. This session will feature expert insights into the clinical aspects of the virus, on-the-ground experiences from outbreak response, and future preparedness strategies. There will be two expert presentations, followed by an interactive Q&A session, providing an opportunity for engaging discussions. Don’t miss the chance to stay informed and engaged on these evolving global health issues.
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Welcome! You are invited to join a meeting: SHEA/PIDS IPC – December 2024. After registering, you will receive a confirmation email about joining the meeting.
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Join us for a collaborative webinar hosted by IDSA and ESCMID to explore critical updates on the Marburg Virus. This session will feature expert insights into the clinical aspects of the virus, on-the-ground experiences from outbreak response, and future preparedness strategies. There will be two expert presentations, followed by an interactive Q&A session, providing an opportunity for engaging discussions. Don’t miss the chance to stay informed and engaged on these evolving global health issues.
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2
In honor of World AIDS Day, the IDSA Foundation will host a webinar, “Advancing HIV Prevention: Strategies, Treatments and Community Impact,” that will focus on advancing HIV prevention and providing updates that equip health care professionals with the knowledge and skills to make a meaningful impact in their practice. Attendees will explore the latest advancements in HIV treatment and prevention, current trends and new treatments in development. The webinar will illustrate effective strategies, demonstrate their application and guide participants on how to translate this knowledge into practice. Learning Objectives: • Summarize the current HIV landscape by reviewing recent scientific and biomedical advancements in HIV treatment, prevention and vaccine research; • Identify key implementation gaps in HIV care, particularly in underserved and minority communities, and discuss strategies to address these disparities; • Examine new and improved HIV interventions under development, focusin
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
In honor of C. diff Awareness Month, the IDSA Foundation invites you to join a webinar that will provide the latest insights on recurrent Clostridioides difficile infection. This session will highlight real-world outcomes from newly approved gut microbial therapies and offer a comprehensive look at the ongoing challenges posed by C. diff, recognized as one of the top five most urgent public health threats. With nearly 500,000 cases annually in the U.S. and up to 29,000 associated deaths, rCDI poses a critical risk, particularly with recurrence rates reaching 30% after an initial infection. The widespread use of antibiotics further increases this risk. Our specialists will discuss the current landscape of C. diff infections and explore innovative approaches to reduce recurrence, focusing on the benefits of GMT. This webinar will offer the opportunity for health care professionals to further their understanding of the epidemiology, treatment advancements and patient care considerations s
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet-
With nearly 500,000 cases annually in the U.S. recurrent C. diff poses a critical risk. Don’t miss our next webinar covering treatment advancements, the role of gut microbial therapies, and strategies to reduce recurrence. Register today ⬇️ 🔗 https://t.co/fzBES3beWk… https://t.co/IQvznEUIyN https://t.co/CH9bnEDq6B
-
-
Mashup Score: 6
In honor of C. diff Awareness Month, the IDSA Foundation invites you to join a webinar that will provide the latest insights on recurrent Clostridioides difficile infection. This session will highlight real-world outcomes from newly approved gut microbial therapies and offer a comprehensive look at the ongoing challenges posed by C. diff, recognized as one of the top five most urgent public health threats. With nearly 500,000 cases annually in the U.S. and up to 29,000 associated deaths, rCDI poses a critical risk, particularly with recurrence rates reaching 30% after an initial infection. The widespread use of antibiotics further increases this risk. Our specialists will discuss the current landscape of C. diff infections and explore innovative approaches to reduce recurrence, focusing on the benefits of GMT. This webinar will offer the opportunity for health care professionals to further their understanding of the epidemiology, treatment advancements and patient care considerations s
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet-
With nearly 500,000 cases annually in the U.S. recurrent C. diff poses a critical risk. Don’t miss our next webinar covering treatment advancements, the role of gut microbial therapies, and strategies to reduce recurrence. Register today ⬇️ 🔗 https://t.co/fzBES3beWk… https://t.co/IQvznEUIyN https://t.co/CH9bnEDq6B
-
-
Mashup Score: 6
Join us as we celebrate Healthy Lung Month with a webinar as part of the Dr. John G. Bartlett Memorial Education Series. Hosted by the IDSA Foundation and Bronchiectasis and NTM 360, a division of the COPD Foundation, this webinar will explore the intricacies of nontuberculous mycobacterial lung disease, unraveling its profound ramifications for patients and explain effective diagnostic and treatment approaches. With a particular focus on the imperative of early diagnosis, this event will shed light on the need to manage NTM in a comprehensive manner. Moreover, attendees will gain valuable insights into the intricate interplay between NTM and bronchiectasis, further illuminating the landscape of lung health. Learning Objectives: • Examine the epidemiology of NTM lung disease, including its causes and prevalence, and identify the common pathogens associated with NTM; • Contrast NTM and bronchiectasis in terms of their pathophysiology and examine the underlying mechanisms linking NTM wit
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Join us as we celebrate Healthy Lung Month with a webinar as part of the Dr. John G. Bartlett Memorial Education Series. Hosted by the IDSA Foundation and Bronchiectasis and NTM 360, a division of the COPD Foundation, this webinar will explore the intricacies of nontuberculous mycobacterial lung disease, unraveling its profound ramifications for patients and explain effective diagnostic and treatment approaches. With a particular focus on the imperative of early diagnosis, this event will shed light on the need to manage NTM in a comprehensive manner. Moreover, attendees will gain valuable insights into the intricate interplay between NTM and bronchiectasis, further illuminating the landscape of lung health. Learning Objectives: • Examine the epidemiology of NTM lung disease, including its causes and prevalence, and identify the common pathogens associated with NTM; • Contrast NTM and bronchiectasis in terms of their pathophysiology and examine the underlying mechanisms linking NTM wit
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Join us for collaborative webinar with ESCMID, where we will explore critical updates on two important global health topics: Mpox and H5N1. Experts from ESCMID will provide a European perspective on the latest developments in Mpox, while we dive into key updates and challenges surrounding H5N1. The webinar will feature two presentations followed by a Q&A session, offering an opportunity for interactive discussions and expert insights. Don’t miss the chance to stay informed and engaged on these evolving global health issues. Time: 10am ET / 17:00 CET (Central European Time)
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Join us for collaborative webinar with ESCMID, where we will explore critical updates on two important global health topics: Mpox and H5N1. Experts from ESCMID will provide a European perspective on the latest developments in Mpox, while we dive into key updates and challenges surrounding H5N1. The webinar will feature two presentations followed by a Q&A session, offering an opportunity for interactive discussions and expert insights. Don’t miss the chance to stay informed and engaged on these evolving global health issues. Time: 10am ET / 17:00 CET (Central European Time)
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
Join IDSA and ESCMID to explore critical updates on the Marburg Virus on Thursday, Dec. 12 at 10:00am ET. This session will feature expert insights into the clinical aspects of the virus, on-the-ground experiences and future strategies. Register: https://t.co/AEISwZ5Gu9 https://t.co/cCcVdjTu1N